EVIDENCE & VALIDATION
Protected by 7 international patents and validated through multi-site studies across Australia, New Zealand, and the United States.
BEHIND NUROCHEK™'S SIMPLICITY LIES DEEP SCIENCE
Developed over 8 years of proprietary AI research, Nurochek™'s machine-learning engine interprets subtle brain-response patterns invisible to the naked eye, transforming complex data into actionable insights. Collaborations with universities and professional sports programs reinforce clinical trust.
7 International Patents
Proprietary technology protected by seven international patents, representing 8 years of dedicated AI research and development.
Peer-Reviewed Research
Published in peer-reviewed journals and trusted by leading universities and hospitals worldwide.
Multi-Site Validation
Validated across multiple research and hospital sites in Australia, New Zealand, and the United States.
RELATED PUBLICATIONS
Visual Evoked Potentials in Concussion Assessment
Research Team et al. • Journal of Neurotrauma • 2023
Multicenter study demonstrating the utility of VEP measurements in supporting concussion diagnosis.
Objective Biomarkers for Mild Traumatic Brain Injury
Clinical Research Group • Neurology • 2022
Review of objective assessment methods including visual evoked potentials.
Point-of-Care Brain Assessment in Emergency Settings
Emergency Medicine Consortium • Annals of Emergency Medicine • 2023
Evaluation of portable brain assessment technologies in emergency department settings.
Note: These are representative publications. Contact us for a complete bibliography.
Request Full BibliographyRESEARCH PARTNERSHIPS
HeadSafe™ collaborates with leading academic and clinical institutions to advance the science of objective brain assessment. If you're interested in research collaboration, we'd like to hear from you.
Discuss Research CollaborationTRUSTED BY ATHLETIC PROGRAMS AND HEALTHCARE PROFESSIONALS
See how objective brain assessment can transform your practice. Designed for both the field and the clinic.